ROCKVILLE, Md., Nov. 27 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that the U.S. Food and Drug Administration (FDA) has officially accepted the...
ROCKVILLE, Md., Oct. 31 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that it intends to offer, subject to market conditions and other factors, $100...
ROCKVILLE, Md., Oct. 30 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage...
Presentation Will be Webcast Live and Archived on Company's Web Site
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA Stock Forum), a biopharmaceutical company focused on the development and...